AU2001230689A1 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
AU2001230689A1
AU2001230689A1 AU2001230689A AU3068901A AU2001230689A1 AU 2001230689 A1 AU2001230689 A1 AU 2001230689A1 AU 2001230689 A AU2001230689 A AU 2001230689A AU 3068901 A AU3068901 A AU 3068901A AU 2001230689 A1 AU2001230689 A1 AU 2001230689A1
Authority
AU
Australia
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001230689A
Inventor
Mattias Belting
Niklas Falk
Lars-Ake Fransson
Katrin Mani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
XYLOGEN AB
Original Assignee
XYLOGEN AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by XYLOGEN AB filed Critical XYLOGEN AB
Publication of AU2001230689A1 publication Critical patent/AU2001230689A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001230689A 2000-01-31 2001-01-31 Novel compounds Abandoned AU2001230689A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0000303 2000-01-31
SE0000303A SE0000303D0 (en) 2000-01-31 2000-01-31 Novel compounds
PCT/SE2001/000167 WO2001054702A1 (en) 2000-01-31 2001-01-30 Novel compounds

Publications (1)

Publication Number Publication Date
AU2001230689A1 true AU2001230689A1 (en) 2001-08-07

Family

ID=20278290

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001230689A Abandoned AU2001230689A1 (en) 2000-01-31 2001-01-31 Novel compounds

Country Status (7)

Country Link
US (1) US20030092637A1 (en)
EP (1) EP1251859A1 (en)
JP (1) JP2003520819A (en)
AU (1) AU2001230689A1 (en)
CA (1) CA2398643A1 (en)
SE (1) SE0000303D0 (en)
WO (1) WO2001054702A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1278547B1 (en) * 2000-04-26 2004-11-03 Cellegy Pharmaceuticals, Inc Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
US20050142217A1 (en) * 2000-04-26 2005-06-30 Adams Michael A. Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
US7678391B2 (en) * 2000-04-26 2010-03-16 Queen's University At Kingston Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
IL152397A (en) * 2002-10-21 2009-02-11 Hadasit Med Res Service Compositions and compounds for the treatment of hyperglycemia
SE0401871D0 (en) * 2004-07-15 2004-07-15 Glucogene Medical Hfm Ab New compositions
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
WO2014097318A2 (en) * 2012-12-18 2014-06-26 Godavari Biorefineries Limited Agents for eliminating tumour-initiating cells
EP3270907A1 (en) * 2015-03-20 2018-01-24 Sammy Oyoo OPIYO Use of suramin and arginase inhibitors in malignant neoplasia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0118676B1 (en) * 1980-12-09 1987-09-23 Seikagaku Kogyo Co. Ltd. D-xylopyranoside series compounds and therapeutical compositions containing same
US5104856A (en) * 1990-11-09 1992-04-14 Uab Research Foundation Heparan sulfate biosynthesis primers
JP3514493B2 (en) * 1993-09-20 2004-03-31 生化学工業株式会社 S-β-D-xylopyranoside compound

Also Published As

Publication number Publication date
EP1251859A1 (en) 2002-10-30
SE0000303D0 (en) 2000-01-31
US20030092637A1 (en) 2003-05-15
JP2003520819A (en) 2003-07-08
WO2001054702A1 (en) 2001-08-02
CA2398643A1 (en) 2001-08-02

Similar Documents

Publication Publication Date Title
AU2002218266A1 (en) Novel indanylidene compounds
AU2002225730A1 (en) Compounds
AU2001292518A1 (en) Novel compounds
AU2001265089A1 (en) Rc-timer scheme
AU2001266345A1 (en) Five-membered-ring compound
AU2002359165A1 (en) Novel compounds
AU2001239765A1 (en) Novel compounds
AUPQ661800A0 (en) Insulin-potentiating compounds
AU2001246998A1 (en) Novel compounds
AU2001281965A1 (en) Novel 6-phenylphenanthridines
AU2001253362A1 (en) Novel compounds
AU2001265871A1 (en) Substituted sulfonylaminopyrimidines
AU2002231077A1 (en) Novel compounds
AU2001254731A1 (en) Substituted phenyluracils
AU2001256964A1 (en) Novel compounds
AU2001258255A1 (en) Substituted benzoylcyclohexenones
AU2002225724A1 (en) Motilide compounds
AU2001220281A1 (en) Rollerboard for road-skiing
AU2001230689A1 (en) Novel compounds
AU2002217285A1 (en) Compounds
AU2002216060A1 (en) Novel compounds
AU2002221923A1 (en) Novel compounds
AU2001276890A1 (en) Novel compounds
AUPQ575300A0 (en) New compound
AU2001237533A1 (en) Novel p-gp-inhibiting compounds